跳至主要内容
临床试验/CTRI/2025/03/081497
CTRI/2025/03/081497尚未招募不适用

Feasibility, sensitivity and detection rate of Sentinel Lymph Node Mapping Using hand-held NIR Fluorescence camera with ICG in Early Stage Endometrial Cancer: A pilot study from a tertiary cancer care Center.

Dr Amy Jose Primary Investigator1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Primary

研究概览

简要总结

Significant advances in the surgical management of endometrial cancer are the safe

adoption of minimally invasive surgery and the use of sentinel lymph node(SLN)

mapping through fluorescence-guided minimally invasive surgery. Several trials

comparing the accuracy of SLN, lymphadenectomy or SNL plus lymphadenectomy have

confirmed that SLN is not inferior in identifying nodal disease.Blue dye,

radiotracer 99mTc and Indocyanine green dye (ICG) are commonly explored in

endometrial cancer, and now, recently, sentinel node mapping using indocyanine green

is much assuring.Blue dye is associated with allergic reactions, and radiolabelled tracer is related to many

logistic challenges and costs despite better detection rates. ICG dye is a fluorescent dye

approved by the FDA. It can be lighted with near-infrared fluorescent light and is

extensively used in intra-operative imaging for better anatomic and functional

information. Our institute has recently acquired the IRILIC NIR handheld camera, which

can be used intra-operatively in open surgery.

Study Method

Prospective, open-labeled, non-randomized exploratory intervention trial

The organisation of work elements

Written informed consent will be obtained from patients who fulfil the inclusion criteria

and are willing to participate in the study.

Intraoperative assessment

After anaesthesia, a laparotomy incision will be made midline vertical. After entry into

the peritoneal cavity, peritoneal wash cytology will be taken. A thorough assessment of

abdominal activity will be conducted to rule out any significant lymph nodes or gross

extrauterine disease. SLN mapping will be started after ruling out extrauterine disease.

SLN Mapping

  1. Intra-cervical injection of ICG at 3 and 9 o’clock positions at concentrations of

1.25mg/ml, submucosally(2-3mm) and deep 1 cm into the stroma, one ml per

injection site. One vial of AUROGREEN ( ICG powder 25mg) will be constituted

with 20 ml of sterile water to obtain the concentration.

  1. Post injection, room lights are switched off to obtain a dark operating room and

almost immediately, the pelvic spaces will be opened to do sentinel mapping

using the hand-held NIR camera.

  1. The sentinel nodes are those identified in proximity to the uterus lighted up in

fluorescent green colour on the NIR camera.

  1. Only lymphatic channels draining to a node are seen, and if the node is not

lightened up, it can also be considered a sentinel node.

  1. Detected nodes will be sent for a staging procedure in the final histopathological

examination with ultra staging.

  1. As this is planned as a pilot study, after SLN mapping, irrespective of the dye

uptake, routine lymphadenectomy as indicated for the histology, grade, and stage

will be done, including pelvic and para-aortic lymphadenectomy.

Schedule

After the approval, 20 consecutive cases of carcinoma endometrium fulfilling the

selection criteria and undergoing staging laparotomy will be recruited for the present

study.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • Biopsy confirmed endometrial carcinoma patients with any histology and grade
  • Clinical and radiological (CT/MRI abdomen and pelvis or whole body PET Ct) early stage endometrial carcinoma undergoing staging laparotomy
  • Willingness to be part of the trial.

排除标准

  • Extra uterine disease or those who received neoadjuvant radiation/ chemotherapy for the present disease or those with previous h/o pelvic irradiation or pelvic node dissection for any cause.

结局指标

主要结局

Primary

时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery

1. Evaluation o feasibility of open ICG fluorescent injection technique for SLN mapping in carcinoma endometrium

时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery

2. To detect the sensitivity and specificity, positive and negative predictive values of open SLN testing in carcinoma endometrium.

时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery

Secondary Objective- To analyse the detection rate- unilateral, bilateral and sites of detection

时间窗: Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing laparotomy surgery. All outcomes are measured at single point, during surgery and at the final pathological confirmation | Day 0, 3 weeks post surgery

次要结局

  • Secondary Objective- To analyse the detection rate- unilateral, bilateral & sites of detection(Study is planned to carry out in first 20 cases of carcinoma endometrium undergoing)

研究者

发起方
Dr Amy Jose Primary Investigator
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Amy Jose

Cancer Institute(WIA) Adyar

研究点 (1)

Loading locations...

相似试验

Checking the practicality and safety to identify... | 临床试验